249 related articles for article (PubMed ID: 12881702)
41. Genomic organisation and expression of BCL6 in murine B-cell lymphomas.
Qi CF; Hori M; Coleman AE; Torrey TA; Taddesse-Heath L; Ye BH; Chattopadhyay SK; Hartley JW; Morse HC
Leuk Res; 2000 Aug; 24(8):719-32. PubMed ID: 10936424
[TBL] [Abstract][Full Text] [Related]
42. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
Eymin B; Dubrez L; Allouche M; Solary E
Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
[TBL] [Abstract][Full Text] [Related]
43. (-)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells.
Takeda S; Nishimura H; Koyachi K; Matsumoto K; Yoshida K; Okamoto Y; Amamoto T; Shindo M; Aramaki H
J Toxicol Sci; 2013; 38(4):547-57. PubMed ID: 23824011
[TBL] [Abstract][Full Text] [Related]
44. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species.
Sentürker S; Tschirret-Guth R; Morrow J; Levine R; Shacter E
Arch Biochem Biophys; 2002 Jan; 397(2):262-72. PubMed ID: 11795881
[TBL] [Abstract][Full Text] [Related]
45. Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma.
Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Detourmignies L; Laï JL; Kerckaert JP
Genes Chromosomes Cancer; 1999 Oct; 26(2):97-105. PubMed ID: 10469447
[TBL] [Abstract][Full Text] [Related]
46. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.
Saito M; Gao J; Basso K; Kitagawa Y; Smith PM; Bhagat G; Pernis A; Pasqualucci L; Dalla-Favera R
Cancer Cell; 2007 Sep; 12(3):280-92. PubMed ID: 17785208
[TBL] [Abstract][Full Text] [Related]
47. Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms.
Muramatsu M; Akasaka T; Kadowaki N; Ohno H; Fukuhara S; Okuma M
Leukemia; 1997 Apr; 11 Suppl 3():318-20. PubMed ID: 9209377
[TBL] [Abstract][Full Text] [Related]
48. The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.
Shi Y; Kuai Y; Lei L; Weng Y; Berberich-Siebelt F; Zhang X; Wang J; Zhou Y; Jiang X; Ren G; Pan H; Mao Z; Zhou R
Oncotarget; 2016 Nov; 7(47):77444-77456. PubMed ID: 27764808
[TBL] [Abstract][Full Text] [Related]
49. Ambivalent role of BCL6 in cell survival and transformation.
Albagli-Curiel O
Oncogene; 2003 Jan; 22(4):507-16. PubMed ID: 12555064
[TBL] [Abstract][Full Text] [Related]
50. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
51. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
[TBL] [Abstract][Full Text] [Related]
52. Novel o-naphthoquinones induce apoptosis of EL-4 T lymphoma cells through the increase of reactive oxygen species.
Di Rosso ME; Barreiro Arcos ML; Elingold I; Sterle H; Baptista Ferreira S; Ferreira VF; Galleano M; Cremaschi G; Dubin M
Toxicol In Vitro; 2013 Oct; 27(7):2094-104. PubMed ID: 23933437
[TBL] [Abstract][Full Text] [Related]
53. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
54. Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin.
Park BS; Baek SJ; Song KH; Kim KH; Jeong SJ; Jeong MH; Seo SY; Lee SW; Yoo KS; Yoo YH
Nutr Cancer; 2002; 42(2):248-55. PubMed ID: 12416267
[TBL] [Abstract][Full Text] [Related]
55. Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.
Jardin F; Ruminy P; Parmentier F; Picquenot JM; Courel MN; Bertrand P; Buchonnet G; Tilly H; Bastard C
Leukemia; 2005 Oct; 19(10):1824-30. PubMed ID: 16094416
[TBL] [Abstract][Full Text] [Related]
56. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
[TBL] [Abstract][Full Text] [Related]
57. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
58. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
59. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
60. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells.
Marshansky V; Wang X; Bertrand R; Luo H; Duguid W; Chinnadurai G; Kanaan N; Vu MD; Wu J
J Immunol; 2001 Mar; 166(5):3130-42. PubMed ID: 11207265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
